Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate COVID-19”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Testing effectiveness (Phase 2)WithdrawnNCT05125562
What this trial is testing

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

Who this might be right for
COVID-19
Direct Biologics, LLC
Large-scale testing (Phase 3)Ended earlyNCT04913675
What this trial is testing

Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.

Who this might be right for
Covid19
Vir Biotechnology, Inc. 1,065
Testing effectiveness (Phase 2)UnknownNCT05947812
What this trial is testing

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Who this might be right for
COVID 19 DiseaseMild to Moderate COVID 19 DiseaseSARS-CoV-2+2 more
60P Australia Pty Ltd 148
Testing effectiveness (Phase 2)Study completedNCT04524663
What this trial is testing

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

Who this might be right for
Covid19
Stanford University 49
Large-scale testing (Phase 3)Ended earlyNCT05541510
What this trial is testing

Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Advagene Biopharma Co. Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT04343651
What this trial is testing

Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19

Who this might be right for
Coronavirus Disease 2019
CytoDyn, Inc. 86
Large-scale testing (Phase 3)Study completedNCT05582629
What this trial is testing

JT001 (VV116) for the Treatment of COVID-19

Who this might be right for
Mild to Moderate COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 1,369
Large-scale testing (Phase 3)UnknownNCT05908071
What this trial is testing

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shenzhen Kexing Pharmaceutical Co., Ltd. 1,200
Not applicableUnknownNCT05894603
What this trial is testing

Effectiveness and Safety of New Oral Antivirals for COVID-19

Who this might be right for
COVID-19
Universidade do Porto 211
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Early research (Phase 1)UnknownNCT04686539
What this trial is testing

Synthetic CBD as a Therapy for COVID-19

Who this might be right for
Covid19CBD
Sheba Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT05676073
What this trial is testing

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shenzhen Kexing Pharmaceutical Co., Ltd. 91
Testing effectiveness (Phase 2)Study completedNCT04419025
What this trial is testing

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

Who this might be right for
COVIDSars-CoV2SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere+1 more
Cambridge Health Alliance 165
Large-scale testing (Phase 3)Ended earlyNCT04521296
What this trial is testing

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Who this might be right for
Mild to Moderate COVID-19
Daewoong Pharmaceutical Co. LTD. 432
Testing effectiveness (Phase 2)UnknownNCT06042764
What this trial is testing

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Who this might be right for
Infection of Upper Respiratory Tract Caused by 2019-nCoV
Sinovac Life Sciences Co., Ltd. 150
Large-scale testing (Phase 3)UnknownNCT04411433
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19

Who this might be right for
Sars-CoV2COVID-19
Ministry of Health, Turkey 1,008
Large-scale testing (Phase 3)Study completedNCT06197217
What this trial is testing

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Who this might be right for
Mild to Moderate COVID-19
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. 1,350
Large-scale testing (Phase 3)Study completedNCT04602000
What this trial is testing

Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Celltrion 1,642
Post-approval studies (Phase 4)Study completedNCT04709172
What this trial is testing

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

Who this might be right for
COVID-19 Pneumonia
Meiji Pharma Spain S.A. 20
Large-scale testing (Phase 3)Study completedNCT04486313
What this trial is testing

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Who this might be right for
COVID-19
Romark Laboratories L.C. 935
Next Page